Latest BRCA1 Stories
BRCA Share(TM) is a novel public-private initiative designed to enhance the clarity and quality of patient testing MADISON, N.J.
GUILDFORD, United Kingdom, April 21, 2015 /PRNewswire/ -- ANGLE plc (AIM:AGL OTCQX:ANPCY), the specialist medtech company, is delighted to announce that the Medical University of Vienna, one of its
A magnetic resonance spectroscopy technique that monitors biochemical changes in tissue could improve the management of women at risk of breast cancer, according to a new study published online,
Goal of Enabling Affordable, Large-Scale BRCA1 and BRCA2 Screening for General Population FREMONT, Calif., Feb. 19, 2015 /PRNewswire/ -- WaferGen Bio-systems, Inc.
Agreement ensures continuing broad patient access to Quest's BRCAvantage(TM) services for evaluating genetic risk of developing breast, ovarian and other cancers MADISON, N.J., Feb.
-- Findings could lead to new therapies for breast, ovarian, and other cancers NEW YORK, Feb.
A team of UK researchers led by Oxford University scientists has devised a new test that could help doctors diagnose breast cancer earlier by detecting changes in a person’s zinc levels.
First major service extension to the company's BRCAvantage(TM) BRCA1 and BRCA2 mutation test menu offers screening for five new non-BRCA genes shown to increase risk of inherited breast cancer MADISON,
HealthForumOnline (HFO) has recently updated The Psychosocial Needs of Women Undergoing Genetic Counseling and Testing in the Breast Cancer Context, an online continuing education (CE) course
- Emitting flashes of light; glittering.